The hypothesis of this 3 year, prospective randomized multicenter efficacy trial is that a structured life-style intervention program with exercise training and mediterranean diet is effective regarding increased adherence to a mediterranean diet, reduction of body mass index, and increase of physical fitness.
BRCA1/2 mutation carriers have a considerably increased risk to develop breast and ovarian cancer during their lifetime. There is evidence from the literature that for sporadic breast cancer disease risk and the course of disease can be significantly influenced by physical activity, nutrition and weight. The hypothesis of this 3 year, prospective randomized multicenter efficacy trial is that a structured life-style intervention program with exercise training and mediterranean diet is effective regarding increased adherence to a mediterranean diet, reduction of body mass index, and increase of physical fitness.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Enrollment
600
Structured exercise training plus mediterranean diet
Humboldt Universität zu Berlin
Berlin, Germany
RECRUITINGMediterranean Diet Adherence Screener (MEDAS) Score (Questionnaire)
Adherence to mediterranean diet
Time frame: 12 months
body mass index (BMI)
Body weight (in kilograms) divided by body height (in meters) squared.
Time frame: 12 months
ventilatory threshold 1 (VT1) in spiroergometry
ventilatory threshold VT1 in spiroergometry
Time frame: 12 months
stress coping capacity, as measured by the Trier Inventory for Chronic Stress (TICS) questionnaire
(TICS) questionnaire
Time frame: 3, 12, 24, 36 months
grade of optimism, as measured by the Life Orientation Test (LOT) questionnaire
Life Orientation Test (LOT)
Time frame: 3, 12, 24, 36 months
attitudes and beliefs regarding physical training and healthy diet, as measured by the "Bewertung körperlicher Aktivität und Ernährung" (BKAE) questionnaire
(BKAE) questionnaire
Time frame: 3, 12, 24, 36 months
quality of life, as measured by the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 (EORTC QLQ-C30)
(EORTC QLQ-C30)
Time frame: 3, 12, 24, 36 months
maximum oxygen consumption (VO2max), as measured by spiroergometry
spiroergometry
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Uniklinikum Köln
Cologne, Germany
Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden
Dresden, Germany
RECRUITINGUniversitätsklinikum Düsseldorf
Düsseldorf, Germany
RECRUITINGKliniken Essen-Mitte
Essen, Germany
RECRUITINGUniversitätsklinikum Essen
Essen, Germany
RECRUITINGUniversitätsklinikum Freiburg
Freiburg im Breisgau, Germany
RECRUITINGUniversitätsmedizin Göttingen
Göttingen, Germany
RECRUITINGUniversitätsklinikum Hamburg-Eppendorf
Hamburg, Germany
RECRUITINGMedizinische Hochschule Hannover
Hanover, Germany
RECRUITING...and 9 more locations
Time frame: 3, 12 months
physical activity, as measured by the International Physical Activity Questionnaire (IPAQ)
Physical Activity
Time frame: 3, 12, 24, 36 months
incidence of breast cancer
During study
Time frame: 12, 24, 36 months
Mediterranean Diet Adherence Screener (MEDAS) Score
(MEDAS) Score
Time frame: 3, 6, 9, 12, 24, 36 months
body mass index (BMI)
(BMI)
Time frame: 3, 12, 24, 36 months
change of maximum oxygen consumption (VO2max) at ventilation threshold 1 (VT1), as measured by spiroergometry
spiroergometry
Time frame: 3, 12 months
mortality rate
During study
Time frame: 12, 24, 36 months
satisfaction (questionnaire)
satisfaction (questionnaire)
Time frame: 3, 12, 24, 36 months
tobacco consumption
survey
Time frame: 12, 24, 36 months
alcohol consumption
survey
Time frame: 12, 24, 36 months
dietary habits and calory intake, as measured by the European Prospective Investigation into Cancer and Nutrition Study Food Frequency Questionnaire (EPIC-FFQ)
(EPIC-FFQ)
Time frame: 3, 12, 24, 36 months
serum cholesterol, serum high density lipoprotein cholesterol,serum, serum Glucose, triglycerides, c-reactive Protein, serum Insulin,proneurotensin
Blood Test
Time frame: 3, 12, 24, 36 months
proenkephalin
Genetic test
Time frame: 3, 12, 24, 36 months
Omega 3 fatty acid in the erythrocyte Membrane, Omega 6 fatty acid level in the erythrocyte Membraserum low density, lipoprotein cholesterolne, Omega 9 fatty acid level in the erythrocyte Membrane,
Blood Test
Time frame: 3, 12, 24, 36 months